Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

B of A Securities Maintains Buy on Addus HomeCare, Raises Price Target to $118

Author: Benzinga Newsdesk | May 07, 2024 06:56am
B of A Securities analyst Joanna Gajuk maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the price target from $115 to $118.

Posted In: ADUS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist